Publications

Showing entries 1 - 20 out of 35

2024


Zuffa S, Schmid R, Bauermeister A, Paulo PW, Caraballo-Rodriguez AM, El Abiead Y et al. microbeMASST: a taxonomically informed mass spectrometry search tool for microbial metabolomics data. Nature Microbiology. 2024 Feb;9(2):336-345. doi: 10.1038/s41564-023-01575-9

2023


2022


Irrgeher J, Rampler E, Steininger-Mairinger T. Making waves in analytical chemistry. Analytical and Bioanalytical Chemistry. 2022 Oct;414(25):7335-7336. doi: 10.1007/s00216-022-04273-3

Baier D, Schönhacker-Alte B, Rusz M, Pirker C, Mohr T, Mendrina T et al. The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation. Pharmaceutics. 2022 Jan 20;14(2):238. doi: 10.3390/pharmaceutics14020238

Rampler E, Baker ES, Kirkwood K, Schwaiger-Haber M, Tam M, Jones MA et al. Empowering women and addressing underrepresentation in the field of mass spectrometry. Expert review of proteomics. 2022 Jan 2;19(1):1-3. doi: 10.1080/14789450.2022.2039631

Schoeny H, Rampler E, Chu DB, Schoeberl A, Galvez L, Blaukopf M et al. Achieving Absolute Molar Lipid Concentrations: A Phospholipidomics Cross-Validation Study. Analytical Chemistry. 2022 Jan;94(3):1618-1625. doi: 10.1021/acs.analchem.1c03743

2021


Fronik P, Poetsch I, Kastner A, Mendrina T, Hager S, Hohenwallner K et al. Structure-Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands. Journal of Medicinal Chemistry. 2021 Aug 26;64(16):12132-12151. doi: 10.1021/acs.jmedchem.1c00770

Rampler E, Hermann G, Grabmann G, El Abiead Y, Schoeny H, Baumgartinger C et al. Benchmarking Non-Targeted Metabolomics Using Yeast-Derived Libraries. Metabolites. 2021 Mar;11(3):160. doi: 10.3390/metabo11030160

2020


2019


Showing entries 1 - 20 out of 35